CDER Celebrates Novel Approvals and Highlights Other Firsts in 2017

Drug Industry Daily
A A
CDER achieved numerous firsts in its past year of drug approvals, covering treatments for several rare diseases, cancer therapies and antibiotics.

To View This Article:

Login

Subscribe To Drug Industry Daily